Ivan Pradilla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ivan Pradilla has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- María Alejandra Palacios-Ariza
Fundación Universitaria Sanitas
2 shared publications - Alberto Velez-Van-Meerbeke
Neuroscience Research Group (Neuros), Centro de Neurociencia—Neurovitae, School of Medicine and Health Sciences, Universidad del Rosario, Carrera 24 #63c-69, Bogotá 111221, Colombia
1 shared publication - Camilo Andrés Romero
Servicio de Neurología, La Cardio, Bogotá, Colombia
1 shared publication Carlos Kamiya‐Matsuoka
Department of Neuro‐Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA
1 shared publicationChirag B. Patel
Department of Neuro‐Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA
1 shared publication- Claudia Talero-Gutiérrez
School of Medicine and Health Sciences, Neuroscience Research Group (Neuros), Centro de Neurociencia - Neurovitae, Universidad del Rosario, Bogotá, Colombia
1 shared publication
Latest Publications
- Open Access
- 23 July 2026
- Published by Wiley in Molecular Carcinogenesis
- Vol. 65 (10) , 1343-1350
Clinical and Molecular Features of BAP1‐Mutated Meningiomas: Case Series
BRCA1‐associated protein 1 (BAP1)‐deficient meningiomas represent a clinically and molecularly distinct subgroup with variable histology and aggressive behavior that may not be fully captured by current grading criteria. The clinical spectrum of BAP1 alterations in meningiomas, including both somatic and germline contexts, remains incompletely characterized. We report three cases of BAP1‐deficient meningiomas with divergent clinical trajectories. Case 1 was a 44‐year‐old woman with a somatic BAP1 nonsense mutation (Q392*) presenting as recurrent spinal meningiomatosis. Despite WHO grade 1 histology with rhabdoid features and no high‐grade criteria, she experienced rapid recurrence and required multiple resections, radiation, and systemic therapy, illustrating that truncating somatic mutations may drive aggressive behavior independent of histological grade. Case 2 was a 22‐year‐old man harboring a germline BAP1 truncating mutation (R385*) with a family history of meningioma, who presented with a WHO grade 3 papillary meningioma and remained progression‐free 24 months after resection and adjuvant radiotherapy. His family pedigree represents a rare phenotype within the BAP1 tumor predisposition syndrome. Case 3 was a 57‐year‐old man with a low‐variant‐allele‐frequency BAP1 missense mutation (Y173C) and WHO grade 2 meningioma who demonstrated a favorable course at 26 months following gross total resection without adjuvant therapy. These cases illustrate the phenotypic heterogeneity of BAP1‐deficient meningiomas and underscore that truncating mutations, particularly somatic ones, may confer aggressive behavior regardless of histological grade. Variant allele frequency and mutation type should inform risk stratification alongside traditional pathological features. Consideration of BAP1 as a defining molecular feature in future WHO classification iterations is likely warranted.
- 23 July 2026
- Published by Wiley in Molecular Carcinogenesis
- Vol. 65 (10) , 1343-1350
Open AccessClinical and Molecular Features of BAP1‐Mutated Meningiomas: Case Series
BRCA1‐associated protein 1 (BAP1)‐deficient meningiomas represent a clinically and molecularly distinct subgroup with variable histology and aggressive behavior that may not be fully captured by current grading criteria. The clinical spectrum of BAP1 alterations in meningiomas, including both somatic and germline contexts, remains incompletely characterized. We report three cases of BAP1‐deficient meningiomas with divergent clinical trajectories. Case 1 was a 44‐year‐old woman with a somatic BAP1 nonsense mutation (Q392*) presenting as recurrent spinal meningiomatosis. Despite WHO grade 1 histology with rhabdoid features and no high‐grade criteria, she experienced rapid recurrence and required multiple resections, radiation, and systemic therapy, illustrating that truncating somatic mutations may drive aggressive behavior independent of histological grade. Case 2 was a 22‐year‐old man harboring a germline BAP1 truncating mutation (R385*) with a family history of meningioma, who presented with a WHO grade 3 papillary meningioma and remained progression‐free 24 months after resection and adjuvant radiotherapy. His family pedigree represents a rare phenotype within the BAP1 tumor predisposition syndrome. Case 3 was a 57‐year‐old man with a low‐variant‐allele‐frequency BAP1 missense mutation (Y173C) and WHO grade 2 meningioma who demonstrated a favorable course at 26 months following gross total resection without adjuvant therapy. These cases illustrate the phenotypic heterogeneity of BAP1‐deficient meningiomas and underscore that truncating mutations, particularly somatic ones, may confer aggressive behavior regardless of histological grade. Variant allele frequency and mutation type should inform risk stratification alongside traditional pathological features. Consideration of BAP1 as a defining molecular feature in future WHO classification iterations is likely warranted.
- Open Access
- 26 April 2026
- Published by Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz in Salud mental
- Vol. 49 (2) , 91-98
Executive Function Evaluation in a Population of Children and Adolescents with Hearing Loss in Bogotá, Colombia
Introduction. Hearing loss, regardless of the degree or etiology, delays language acquisition and communication skills and consequently executive function development. Objective. The aim of this study is to measure executive function performance in a population of children and adolescents with hearing loss in Bogotá, Colombia. Method. TA cross-sectional observational study was conducted with participants between 5 and 16 years old with prelingual hearing loss and no previous diagnosis of intellectual disability. Six subtests were selected from the Child Neuropsychological Scale to evaluate performance in the following domains: planning and organizing, visual memory, non-semantic graphic fluency, cognitive flexibility, and attention. Results. Overall, percentile mean scores for the total population were average or above average for all subtests. Subjects scored lowest in visual memory domains, including both encoding and recall skills and highest in attention and non-semantic graphic fluency subtests. No significant associations were observed between independent variables (age at diagnosis, chronological age, degree of HL, type of hearing aid, and sex) and subtests scores. Discussion and conclusion. Although hearing loss can delay executive function development, our sample of Colombian children and adolescents with hearing loss receiving multidisciplinary therapy reported similar executive function performance to their normal hearing peers.
- 26 April 2026
- Published by Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz in Salud mental
- Vol. 49 (2) , 91-98
Open AccessExecutive Function Evaluation in a Population of Children and Adolescents with Hearing Loss in Bogotá, Colombia
Introduction. Hearing loss, regardless of the degree or etiology, delays language acquisition and communication skills and consequently executive function development. Objective. The aim of this study is to measure executive function performance in a population of children and adolescents with hearing loss in Bogotá, Colombia. Method. TA cross-sectional observational study was conducted with participants between 5 and 16 years old with prelingual hearing loss and no previous diagnosis of intellectual disability. Six subtests were selected from the Child Neuropsychological Scale to evaluate performance in the following domains: planning and organizing, visual memory, non-semantic graphic fluency, cognitive flexibility, and attention. Results. Overall, percentile mean scores for the total population were average or above average for all subtests. Subjects scored lowest in visual memory domains, including both encoding and recall skills and highest in attention and non-semantic graphic fluency subtests. No significant associations were observed between independent variables (age at diagnosis, chronological age, degree of HL, type of hearing aid, and sex) and subtests scores. Discussion and conclusion. Although hearing loss can delay executive function development, our sample of Colombian children and adolescents with hearing loss receiving multidisciplinary therapy reported similar executive function performance to their normal hearing peers.
- Open Access
- 23 June 2024
- Published by Universidad Industrial de Santander in Revista Médicas UIS
- Vol. 37 (2) , 65-76
Variabilidad en los criterios de evaluación de trombofilia de médicos especialistas, en pacientes adultos con trombosis arterial: Colombia, septiembre 2021 a enero de 2022
Introducción: la trombofilia es un grupo de desórdenes sanguíneos, adquiridos o hereditarios, caracterizado por una predisposición a la formación de trombos venosos o arteriales. En la práctica clínica, hay variabilidad en los criterios de selección de pacientes a estudiar y en las pruebas de laboratorio a solicitar para trombofilia en trombosis arterial. Objetivo: describir los criterios de médicos especialistas colombianos para la evaluación de trombofilias en pacientes adultos con trombosis arterial y determinar la variabilidad de estos. Métodos: entre septiembre 2021 y enero 2022, mediante encuesta virtual a médicos especialistas en Colombia al cuidado de pacientes con trombosis arterial, se indagó sobre los criterios de selección de pacientes a estudiar y estudios a solicitar para trombofilias en casos de trombosis arterial. Los médicos encuestados fueron seleccionados por conveniencia, fueron contactados personalmente o vía correo electrónico. Resultados: 102 encuestas, se observaron 44 patrones de criterios de selección para estudio de trombofilias en casos de trombosis arterial (índice de variabilidad de 42,57 %). Los dos patrones más frecuentes incluían la historia familiar, la trombosis arterial recurrente, edad 50 %) para el estudio de trombofilias en pacientes con trombosis arterial fueron anticuerpos anticardiolipinas (95,1 %), anticoagulante lúpico (95,1 %). Conclusión: existe variabilidad entre médicos especialistas colombianos al cuidado de pacientes adultos con trombosis arterial en los criterios de selección y pruebas de laboratorio a solicitar para el estudio de trombofilias.
- 23 June 2024
- Published by Universidad Industrial de Santander in Revista Médicas UIS
- Vol. 37 (2) , 65-76
Open AccessVariabilidad en los criterios de evaluación de trombofilia de médicos especialistas, en pacientes adultos con trombosis arterial: Colombia, septiembre 2021 a enero de 2022
Introducción: la trombofilia es un grupo de desórdenes sanguíneos, adquiridos o hereditarios, caracterizado por una predisposición a la formación de trombos venosos o arteriales. En la práctica clínica, hay variabilidad en los criterios de selección de pacientes a estudiar y en las pruebas de laboratorio a solicitar para trombofilia en trombosis arterial. Objetivo: describir los criterios de médicos especialistas colombianos para la evaluación de trombofilias en pacientes adultos con trombosis arterial y determinar la variabilidad de estos. Métodos: entre septiembre 2021 y enero 2022, mediante encuesta virtual a médicos especialistas en Colombia al cuidado de pacientes con trombosis arterial, se indagó sobre los criterios de selección de pacientes a estudiar y estudios a solicitar para trombofilias en casos de trombosis arterial. Los médicos encuestados fueron seleccionados por conveniencia, fueron contactados personalmente o vía correo electrónico. Resultados: 102 encuestas, se observaron 44 patrones de criterios de selección para estudio de trombofilias en casos de trombosis arterial (índice de variabilidad de 42,57 %). Los dos patrones más frecuentes incluían la historia familiar, la trombosis arterial recurrente, edad 50 %) para el estudio de trombofilias en pacientes con trombosis arterial fueron anticuerpos anticardiolipinas (95,1 %), anticoagulante lúpico (95,1 %). Conclusión: existe variabilidad entre médicos especialistas colombianos al cuidado de pacientes adultos con trombosis arterial en los criterios de selección y pruebas de laboratorio a solicitar para el estudio de trombofilias.
- 5 July 2023
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 182 (9) , 4103-4112
Effectiveness of non-immersive virtual reality in the management of procedure-related pain in preschool children: a randomized clinical trial
The objective of this study is to assess the effectiveness of non-immersive virtual reality as a pain-distraction measure in children between the ages of 3 and 5 years undergoing painful injection procedures in an outpatient setting. We carried out a randomized, unmasked clinical trial in children undergoing venipuncture or intramuscular injection procedures. Patients were randomized to a distraction virtual reality video or standard care. After the procedure, three independent observers (parents, researchers, nursing staff) rated pain on the LLANTO pain scale. We recruited 122 subjects, half of which were randomized to virtual reality. The median age was of approximately 60 months (IQR: 15 months), and the sample was balanced with regard to sex. There were significant differences in LLANTO scales scores between the VR subjects and controls of − 3.34 (95% CI − 4.15; − 2.54), − 3.02 (95% CI − 3.90; − 2.14), and − 2.98 (95% CI − 3.87; − 2.09), as rated by parents, researchers, and nursing staff, respectively. Agreement between raters was high for all three types of observers, with Cohen Kappas over 0.79 in all cases. Bivariate analysis showed reductions in the risk of obtaining higher scores in the LLANTO scale. Linear regression models showed a reduction of approximately 3 points in the scale, regardless of the type of observer. These models were adjusted for sex, age, kind of procedure, use of prior analgesia, and recruitment center. Conclusions: Non-immersive virtual reality is an effective adjunctive therapy for the reduction of pain in children undergoing painful injection procedures in an outpatient setting. This strategy may be used to improve the quality of care in pediatric outpatient services. Trial registration: ClinicalTrials.gov Identifier: NCT03985930 (Registered June 14, 2019). What is Known: •The use of immersive virtual reality (VR) has been described as an effective adjunctive distraction method during painful procedures in children over 5 years. What is New: •The utility of non-immersive VR in children below that age is not yet clear. This randomized clinical trial comparing non-immersive VR vs. standard care showed an average reduction of three points in the LLANTO pain scale favoring non-immersive VR. Non-immersive VR is an effective and inexpensive non-pharmacological technique that reduces fear and pain in pediatric patients.
- 5 July 2023
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 182 (9) , 4103-4112
Effectiveness of non-immersive virtual reality in the management of procedure-related pain in preschool children: a randomized clinical trial
The objective of this study is to assess the effectiveness of non-immersive virtual reality as a pain-distraction measure in children between the ages of 3 and 5 years undergoing painful injection procedures in an outpatient setting. We carried out a randomized, unmasked clinical trial in children undergoing venipuncture or intramuscular injection procedures. Patients were randomized to a distraction virtual reality video or standard care. After the procedure, three independent observers (parents, researchers, nursing staff) rated pain on the LLANTO pain scale. We recruited 122 subjects, half of which were randomized to virtual reality. The median age was of approximately 60 months (IQR: 15 months), and the sample was balanced with regard to sex. There were significant differences in LLANTO scales scores between the VR subjects and controls of − 3.34 (95% CI − 4.15; − 2.54), − 3.02 (95% CI − 3.90; − 2.14), and − 2.98 (95% CI − 3.87; − 2.09), as rated by parents, researchers, and nursing staff, respectively. Agreement between raters was high for all three types of observers, with Cohen Kappas over 0.79 in all cases. Bivariate analysis showed reductions in the risk of obtaining higher scores in the LLANTO scale. Linear regression models showed a reduction of approximately 3 points in the scale, regardless of the type of observer. These models were adjusted for sex, age, kind of procedure, use of prior analgesia, and recruitment center. Conclusions: Non-immersive virtual reality is an effective adjunctive therapy for the reduction of pain in children undergoing painful injection procedures in an outpatient setting. This strategy may be used to improve the quality of care in pediatric outpatient services. Trial registration: ClinicalTrials.gov Identifier: NCT03985930 (Registered June 14, 2019). What is Known: •The use of immersive virtual reality (VR) has been described as an effective adjunctive distraction method during painful procedures in children over 5 years. What is New: •The utility of non-immersive VR in children below that age is not yet clear. This randomized clinical trial comparing non-immersive VR vs. standard care showed an average reduction of three points in the LLANTO pain scale favoring non-immersive VR. Non-immersive VR is an effective and inexpensive non-pharmacological technique that reduces fear and pain in pediatric patients.
- Open Access
- 5 August 2021
- Published by PAGEPress Publications in Dermatology Reports
- Vol. 14 (2) , 9308
Peripheral Neuropathy in Leprosy: Clinical Manifestations and Disability in a Colombian National Referral Center
Objective: To describe the neurological features of the physical examination in patients with Hansen’s disease who were treated in Bogotá, Colombia.Methods: We carried out a descriptive study of all patients with a Hansen’s disease diagnosis treated at a referral center between 2003-2018.Results: There were 327 eligible electronic health records (EHRs) with a final sample of 282 subjects. Leprosy was most common in males (57.45%), median age at the diagnosis was 54 years, and lesions of the lower limbs were more common (75.1%). The median time from disease onset to consult was 12 months. Most of them were classified as having lepromatous leprosy (39.7%). Pain over the median nerve trunk was the most common manifestation of disease (28%), followed by pain over the radial trunk (22%). Sensitive alterations were more common than motor ones. Specifically, the posterior tibial nerve was affected in nearly half of subjects. Dual impairment was more common in the ulnar nerve (13.8%). Some disability was apparent in 23.8% of subjects; predominantly grade 1 disability.Conclusion: Findings regarding age, leprosy type, and the frequency of individual nerve compromise were consistent with reports from other countries. Nerve trunk thickening was infrequent, which might be a consequence of subjectiveness in the examination and sample differences in sex distribution, degree of disability and time since disease onset. The frequency of morbidity and disability found in this sample, though low when compared with other series, fails to meet public health goals, including those limiting disability in younger subjects.
- 5 August 2021
- Published by PAGEPress Publications in Dermatology Reports
- Vol. 14 (2) , 9308
Open AccessPeripheral Neuropathy in Leprosy: Clinical Manifestations and Disability in a Colombian National Referral Center
Objective: To describe the neurological features of the physical examination in patients with Hansen’s disease who were treated in Bogotá, Colombia.Methods: We carried out a descriptive study of all patients with a Hansen’s disease diagnosis treated at a referral center between 2003-2018.Results: There were 327 eligible electronic health records (EHRs) with a final sample of 282 subjects. Leprosy was most common in males (57.45%), median age at the diagnosis was 54 years, and lesions of the lower limbs were more common (75.1%). The median time from disease onset to consult was 12 months. Most of them were classified as having lepromatous leprosy (39.7%). Pain over the median nerve trunk was the most common manifestation of disease (28%), followed by pain over the radial trunk (22%). Sensitive alterations were more common than motor ones. Specifically, the posterior tibial nerve was affected in nearly half of subjects. Dual impairment was more common in the ulnar nerve (13.8%). Some disability was apparent in 23.8% of subjects; predominantly grade 1 disability.Conclusion: Findings regarding age, leprosy type, and the frequency of individual nerve compromise were consistent with reports from other countries. Nerve trunk thickening was infrequent, which might be a consequence of subjectiveness in the examination and sample differences in sex distribution, degree of disability and time since disease onset. The frequency of morbidity and disability found in this sample, though low when compared with other series, fails to meet public health goals, including those limiting disability in younger subjects.